The global Steroids APIs market size is predicted to grow from US$ 12981 million in 2025 to US$ 18980 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Steroids API (Active Pharmaceutical Ingredient) refers to the key bioactive compounds used in the manufacturing of steroid-based medications, including corticosteroids, anabolic steroids, and sex hormones such as testosterone, estradiol, and progesterone. These APIs are produced through chemical synthesis or fermentation processes and are essential for treating a wide range of medical conditions, including inflammation, autoimmune diseases, hormonal imbalances, asthma, and certain cancers. As the core therapeutic component in formulations like tablets, injectables, creams, and inhalers, steroids APIs must meet strict regulatory standards for purity, potency, and safety set by authorities like the FDA and EMA.
Key market drivers for the Steroids API industry include the rising prevalence of chronic conditions such as asthma, arthritis, and hormonal disorders, which fuel demand for corticosteroids and sex hormone APIs. An aging global population is accelerating the use of estrogen, progesterone, and testosterone APIs for hormone replacement therapy, while the expanding generic drug market—particularly in developing countries—is boosting demand for cost-effective steroid formulations. Regionally, North America leads due to high prescription rates and strong CDMO activity, while Europe follows with a robust regulatory framework and established pharma manufacturers. India and China dominate bulk steroid API production, offering cost advantages and vast manufacturing capacity, whereas Latin America and Africa are emerging as new demand centers amid improving healthcare infrastructure and regulatory alignment.
The “Steroids APIs Industry Forecast” looks at past sales and reviews total world Steroids APIs sales in 2024, providing a comprehensive analysis by region and market sector of projected Steroids APIs sales for 2025 through 2031. With Steroids APIs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Steroids APIs industry.
This Insight Report provides a comprehensive analysis of the global Steroids APIs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Steroids APIs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Steroids APIs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Steroids APIs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Steroids APIs.
This report presents a comprehensive overview, market shares, and growth opportunities of Steroids APIs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Corticosteroids APIs
Sex Hormone Steroids APIs
Segmentation by Application:
Human Pharmaceuticals
Veterinary Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Sanofi
GSK
Merck
Bayer
Teva
Cambrex
Olon
Axplora
Aspen API
Symbiotec
Lupin
Cipla
Ipca Laboratories
Henan Lihua
Hubei Gedian
Key Questions Addressed in this Report
What is the 10-year outlook for the global Steroids APIs market?
What factors are driving Steroids APIs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Steroids APIs market opportunities vary by end market size?
How does Steroids APIs break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Steroids APIs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Steroids APIs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Steroids APIs by Country/Region, 2020, 2024 & 2031
2.2 Steroids APIs Segment by Type
2.2.1 Corticosteroids APIs
2.2.2 Sex Hormone Steroids APIs
2.3 Steroids APIs Sales by Type
2.3.1 Global Steroids APIs Sales Market Share by Type (2020-2025)
2.3.2 Global Steroids APIs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Steroids APIs Sale Price by Type (2020-2025)
2.4 Steroids APIs Segment by Application
2.4.1 Human Pharmaceuticals
2.4.2 Veterinary Medicine
2.4.3 Others
2.5 Steroids APIs Sales by Application
2.5.1 Global Steroids APIs Sale Market Share by Application (2020-2025)
2.5.2 Global Steroids APIs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Steroids APIs Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Steroids APIs Breakdown Data by Company
3.1.1 Global Steroids APIs Annual Sales by Company (2020-2025)
3.1.2 Global Steroids APIs Sales Market Share by Company (2020-2025)
3.2 Global Steroids APIs Annual Revenue by Company (2020-2025)
3.2.1 Global Steroids APIs Revenue by Company (2020-2025)
3.2.2 Global Steroids APIs Revenue Market Share by Company (2020-2025)
3.3 Global Steroids APIs Sale Price by Company
3.4 Key Manufacturers Steroids APIs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Steroids APIs Product Location Distribution
3.4.2 Players Steroids APIs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Steroids APIs by Geographic Region
4.1 World Historic Steroids APIs Market Size by Geographic Region (2020-2025)
4.1.1 Global Steroids APIs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Steroids APIs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Steroids APIs Market Size by Country/Region (2020-2025)
4.2.1 Global Steroids APIs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Steroids APIs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Steroids APIs Sales Growth
4.4 APAC Steroids APIs Sales Growth
4.5 Europe Steroids APIs Sales Growth
4.6 Middle East & Africa Steroids APIs Sales Growth
5 Americas
5.1 Americas Steroids APIs Sales by Country
5.1.1 Americas Steroids APIs Sales by Country (2020-2025)
5.1.2 Americas Steroids APIs Revenue by Country (2020-2025)
5.2 Americas Steroids APIs Sales by Type (2020-2025)
5.3 Americas Steroids APIs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Steroids APIs Sales by Region
6.1.1 APAC Steroids APIs Sales by Region (2020-2025)
6.1.2 APAC Steroids APIs Revenue by Region (2020-2025)
6.2 APAC Steroids APIs Sales by Type (2020-2025)
6.3 APAC Steroids APIs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Steroids APIs by Country
7.1.1 Europe Steroids APIs Sales by Country (2020-2025)
7.1.2 Europe Steroids APIs Revenue by Country (2020-2025)
7.2 Europe Steroids APIs Sales by Type (2020-2025)
7.3 Europe Steroids APIs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Steroids APIs by Country
8.1.1 Middle East & Africa Steroids APIs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Steroids APIs Revenue by Country (2020-2025)
8.2 Middle East & Africa Steroids APIs Sales by Type (2020-2025)
8.3 Middle East & Africa Steroids APIs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Steroids APIs
10.3 Manufacturing Process Analysis of Steroids APIs
10.4 Industry Chain Structure of Steroids APIs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Steroids APIs Distributors
11.3 Steroids APIs Customer
12 World Forecast Review for Steroids APIs by Geographic Region
12.1 Global Steroids APIs Market Size Forecast by Region
12.1.1 Global Steroids APIs Forecast by Region (2026-2031)
12.1.2 Global Steroids APIs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Steroids APIs Forecast by Type (2026-2031)
12.7 Global Steroids APIs Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Steroids APIs Product Portfolios and Specifications
13.1.3 Pfizer Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Steroids APIs Product Portfolios and Specifications
13.2.3 Sanofi Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Steroids APIs Product Portfolios and Specifications
13.3.3 GSK Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Steroids APIs Product Portfolios and Specifications
13.4.3 Merck Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Steroids APIs Product Portfolios and Specifications
13.5.3 Bayer Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Steroids APIs Product Portfolios and Specifications
13.6.3 Teva Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Cambrex
13.7.1 Cambrex Company Information
13.7.2 Cambrex Steroids APIs Product Portfolios and Specifications
13.7.3 Cambrex Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cambrex Main Business Overview
13.7.5 Cambrex Latest Developments
13.8 Olon
13.8.1 Olon Company Information
13.8.2 Olon Steroids APIs Product Portfolios and Specifications
13.8.3 Olon Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Olon Main Business Overview
13.8.5 Olon Latest Developments
13.9 Axplora
13.9.1 Axplora Company Information
13.9.2 Axplora Steroids APIs Product Portfolios and Specifications
13.9.3 Axplora Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Axplora Main Business Overview
13.9.5 Axplora Latest Developments
13.10 Aspen API
13.10.1 Aspen API Company Information
13.10.2 Aspen API Steroids APIs Product Portfolios and Specifications
13.10.3 Aspen API Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Aspen API Main Business Overview
13.10.5 Aspen API Latest Developments
13.11 Symbiotec
13.11.1 Symbiotec Company Information
13.11.2 Symbiotec Steroids APIs Product Portfolios and Specifications
13.11.3 Symbiotec Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Symbiotec Main Business Overview
13.11.5 Symbiotec Latest Developments
13.12 Lupin
13.12.1 Lupin Company Information
13.12.2 Lupin Steroids APIs Product Portfolios and Specifications
13.12.3 Lupin Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Lupin Main Business Overview
13.12.5 Lupin Latest Developments
13.13 Cipla
13.13.1 Cipla Company Information
13.13.2 Cipla Steroids APIs Product Portfolios and Specifications
13.13.3 Cipla Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Cipla Main Business Overview
13.13.5 Cipla Latest Developments
13.14 Ipca Laboratories
13.14.1 Ipca Laboratories Company Information
13.14.2 Ipca Laboratories Steroids APIs Product Portfolios and Specifications
13.14.3 Ipca Laboratories Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Ipca Laboratories Main Business Overview
13.14.5 Ipca Laboratories Latest Developments
13.15 Henan Lihua
13.15.1 Henan Lihua Company Information
13.15.2 Henan Lihua Steroids APIs Product Portfolios and Specifications
13.15.3 Henan Lihua Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Henan Lihua Main Business Overview
13.15.5 Henan Lihua Latest Developments
13.16 Hubei Gedian
13.16.1 Hubei Gedian Company Information
13.16.2 Hubei Gedian Steroids APIs Product Portfolios and Specifications
13.16.3 Hubei Gedian Steroids APIs Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Hubei Gedian Main Business Overview
13.16.5 Hubei Gedian Latest Developments
14 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
